Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

The Alfred20 enrolled

Overview

The study is designed to evaluate interferon responses to CMV in HIV positive individuals and a component will look at interferon responses to CMV in HIV positive individuals over time after commencement of antiretroviral therapy. We will also look at the correlation between CD4 T cell numbers and HLA type with the interferon response.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV Infection CMV Infection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. HIV positive with history of documented HCV infection 2. Over 18 years old 3. HIV positive 4. Antiretroviral naive, starting on antiretroviral therapy

Locations (1)

Alfred Hospital

Melbourne, Victoria, Australia

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.